Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 16 - 75 |
| Updated: | 8/1/2018 |
| Start Date: | November 10, 2017 |
| End Date: | November 2027 |
| Contact: | Cameron Howes, BA |
| Email: | cameron.howes@duke.edu |
| Phone: | 9196135747 |
The purpose of this study is to assess the functional outcomes in patients undergoing
proximal femur resection and reconstruction with an endoprosthesis, based on the abductor
muscle repair technique. The investigators hypothesize that those patients who receive
reattachment of the abductors directly into the prosthesis will have better functional
outcomes overall. Furthermore, the investigators plan to develop a simple, cost effective,
and reproducible method to assess abductor function at clinical post-operative visits through
plain radiographs.
proximal femur resection and reconstruction with an endoprosthesis, based on the abductor
muscle repair technique. The investigators hypothesize that those patients who receive
reattachment of the abductors directly into the prosthesis will have better functional
outcomes overall. Furthermore, the investigators plan to develop a simple, cost effective,
and reproducible method to assess abductor function at clinical post-operative visits through
plain radiographs.
Patients treated for proximal femur replacements at Duke University Medical Center by
Orthopaedic Oncology trained surgeons. The Duke DEDUCE database will be used to identify
retrospective patients using the above mentioned CPT codes. Individual chart review of the
electronic medical record will then be used to identify those receiving a proximal femur
replacement. Maximum number of charts to be reviewed in the study will be 300. Of these 300
charts, the investigators plan to consent 25 subjects who have return appointments scheduled.
The investigators also plan to consent 25 preoperative patients, for a total of 50 subjects.
Orthopaedic Oncology trained surgeons. The Duke DEDUCE database will be used to identify
retrospective patients using the above mentioned CPT codes. Individual chart review of the
electronic medical record will then be used to identify those receiving a proximal femur
replacement. Maximum number of charts to be reviewed in the study will be 300. Of these 300
charts, the investigators plan to consent 25 subjects who have return appointments scheduled.
The investigators also plan to consent 25 preoperative patients, for a total of 50 subjects.
Inclusion Criteria:
• Has undergone or is scheduled for proximal femur replacement by an Ortho Oncology surgeon
Exclusion Criteria:
- Non-ambulatory before or after the procedure
- Subjects who, in the opinion of the investigator, have not or likely will not complete
at least some portion of the investigator's recommended follow-up
We found this trial at
1
site
Duke University Younger than most other prestigious U.S. research universities, Duke University consistently ranks among...
Click here to add this to my saved trials
